Skip to main content

MoneyWorks4Me

Gujarat Themis Biosyn informs about disclosures

04 Jul 2026 Evaluate
Gujarat Themis Biosyn has informed that the Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 03, 2026 for Pharmaceutical Business Group (India).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1757.10
Dr. Reddys Labs. 1341.20
Cipla 1362.60
Lupin 1985.55
Zydus Lifesciences 1185.00
View more..